Insulin-like growth factor 2 (IGF-2) is necessary for adequate human growth. Overexpression of the IGF2 gene is associated with fetal overgrowth and may play a role in the intrauterine programming of adipose tissue. As obesity in children is a major public health problem associated with early onset of comorbid metabolic diseases, identifying early life markers of obesity may serve as useful tool for counseling and implementation of preventive efforts before obesity develops. The relationship between IGF-2 and body composition is an emerging field of study and existing data are conflicting. In this review, we discuss the IGF2 gene and its function, highlight the proposed mechanisms for the effects of IGF-2 on adiposity, and examine the current literature studying the relationships between IGF-2 levels, changes within the IGF2 gene, weight, and adiposity. With additional study, IGF-2 may emerge as a useful marker of future obesity risk in infants.

Keywords:
Neonatal adiposity, Intrauterine growth, Body composition, Insulin-like growth factor 2
1.
Ogden CL, Carroll MD, Kit BK, Flegal KM: Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014;311:806-814.
2.
Farfel A, Derazne E, Tzur D, Linder N, Laron Z: Anthropometric indices of adolescents who at birth were full-term long and/or overweight for gestational age. Isr Med Assoc J 2012;14:93-95.
3.
Guo SS, Wu W, Chumlea WC, Roche AF: Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. Am J Clin Nutr 2002;76:653-658.
4.
Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH: Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-873.
5.
Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS: The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics 2005;115:22-27.
6.
Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, Schick F, Haring HU, Stumvoll M: Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003;11:368-372.
7.
HAPO Study Cooperative Research Group: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009;58:453-459.
8.
O'Rahilly S, Farooqi IS: The genetics of obesity in humans; in De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO (eds): Endotext. South Dartmouth, MDText.com, Inc., 2000.
9.
Berryman DE: Body composition, adipose tissue, and energy balance; in Laron Z, Kopchick JJ (eds): Laron Syndrome - From Man to Mouse: Lessons from Clinical and Experimental Experience. New York/Heidelberg/Dordrecht, Springer, 2011, pp 441-449.
10.
Berryman DE, List EO, Palmer AJ, Chung MY, Wright-Piekarski J, Lubbers E, O'Connor P, Okada S, Kopchick JJ: Two-year body composition analyses of long-lived GHR null mice. J Gerontol A Biol Sci Med Sci 2010;65:31-40.
11.
List EO, Berryman DE, Funk K, Gosney ES, Jara A, Kelder B, Wang X, Kutz L, Troike K, Lozier N, Mikula V, Lubbers ER, Zhang H, Vesel C, Junnila RK, Frank SJ, Masternak MM, Bartke A, Kopchick JJ: The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol Endocrinol 2013;27:524-535.
12.
Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA: IGF-I is required for normal embryonic growth in mice. Genes Dev 1993;7:2609-2617.
13.
DeChiara TM, Efstratiadis A, Robertson EJ: A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990;345:78-80.
14.
Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche FA: C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993;169:89-97.
15.
Bonapace G, Concolino D, Formicola S, Strisciuglio P: A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 2003;40:913-917.
16.
Woods KA, Camacho-Hubner C, Barter D, Clark AJ, Savage MO: Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr Suppl 1997;423:39-45.
17.
Netchine I, Azzi S, Houang M, Seurin D, Perin L, Ricort JM, Daubas C, Legay C, Mester J, Herich R, Godeau F, Le Bouc Y: Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. J Clin Endocrinol Metab 2009;94:3913-3921.
18.
Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doorn J, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA, Wit JM: Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 2005;90:2855-2864.
19.
Hill DJ: Relative abundance and molecular size of immunoreactive insulin-like growth factors I and II in human fetal tissues. Early Hum Dev 1990;21:49-58.
20.
Delhanty PJ, Han VK: The expression of insulin-like growth factor (IGF)-binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus. Endocrinology 1993;132:41-52.
21.
Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
22.
Fowden AL, Sferruzzi-Perri AN, Coan PM, Constancia M, Burton GJ: Placental efficiency and adaptation: endocrine regulation. J Physiol 2009;587:3459-3472.
23.
Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W: Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002;417:945-948.
24.
Qiu Q, Basak A, Mbikay M, Tsang BK, Gruslin A: Role of pro-IGF-II processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci USA 2005;102:11047-11052.
25.
Bergman D, Halje M, Nordin M, Engstrom W: Insulin-like growth factor 2 in development and disease: a mini-review. Gerontology 2013;59:240-249.
26.
Chao W, D'Amore PA: IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 2008;19:111-120.
27.
Massague J, Czech MP: The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 1982;257:5038-5045.
28.
Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A: Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 1997;11:3128-3142.
29.
Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A: Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 1996;177:517-535.
30.
Cohen MM Jr: Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 2005;8:287-304.
31.
Price SM, Stanhope R, Garrett C, Preece MA, Trembath RC: The spectrum of Silver-Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria. J Med Genet 1999;36:837-842.
32.
Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 2000;106:473-481.
33.
Denley A, Wallace JC, Cosgrove LJ, Forbes BE: The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. Horm Metab Res 2003;35:778-785.
34.
Nezer C, Moreau L, Brouwers B, Coppieters W, Detilleux J, Hanset R, Karim L, Kvasz A, Leroy P, Georges M: An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet 1999;21:155-156.
35.
Aslan O, Hamill RM, Davey G, McBryan J, Mullen AM, Gispert M, Sweeney T: Variation in the IGF2 gene promoter region is associated with intramuscular fat content in porcine skeletal muscle. Mol Biol Rep 2012;39:4101-4110.
36.
Demetriou C, Abu-Amero S, Thomas AC, Ishida M, Aggarwal R, Al-Olabi L, Leon LJ, Stafford JL, Syngelaki A, Peebles D, Nicolaides KH, Regan L, Stanier P, Moore GE: Paternally expressed, imprinted insulin-like growth factor-2 in chorionic villi correlates significantly with birth weight. PLoS One 2014;9:e85454.
37.
Smerieri A, Petraroli M, Ziveri MA, Volta C, Bernasconi S, Street ME: Effects of cord serum insulin, IGF-II, IGFBP-2, IL-6 and cortisol concentrations on human birth weight and length: pilot study. PLoS One 2011;6:e29562.
38.
Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG: Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-1555.
39.
Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, Gramellini D, Bernasconi S: Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol 2006;155:567-574.
40.
Wiznitzer A, Reece EA, Homko C, Furman B, Mazor M, Levy J: Insulin-like growth factors, their binding proteins, and fetal macrosomia in offspring of nondiabetic pregnant women. Am J Perinatol 1998;15:23-28.
41.
Reece EA, Wiznitzer A, Le E, Homko CJ, Behrman H, Spencer EM: The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol 1994;84:88-95.
42.
Christou H, Connors JM, Ziotopoulou M, Hatzidakis V, Papathanassoglou E, Ringer SA, Mantzoros CS: Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab 2001;86:935-938.
43.
Osorio M, Torres J, Moya F, Pezzullo J, Salafia C, Baxter R, Schwander J, Fant M: Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: relationships to fetoplacental growth at term. Early Hum Dev 1996;46:15-26.
44.
Catalano PM, Tyzbir ED, Allen SR, McBean JH, McAuliffe TL: Evaluation of fetal growth by estimation of neonatal body composition. Obstet Gynecol 1992;79:46-50.
45.
De Cunto A, Paviotti G, Ronfani L, Travan L, Bua J, Cont G, Demarini S: Can body mass index accurately predict adiposity in newborns? Arch Dis Child Fetal Neonatal Ed 2014;99:F238-F239.
46.
Roth S, Abernathy MP, Lee WH, Pratt L, Denne S, Golichowski A, Pescovitz OH: Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies. J Soc Gynecol Investig 1996;3:78-84.
47.
Luo ZC, Nuyt AM, Delvin E, Audibert F, Girard I, Shatenstein B, Cloutier A, Cousineau J, Djemli A, Deal C, Levy E, Wu Y, Julien P, Fraser WD: Maternal and fetal IGF-I and IGF-II levels, fetal growth, and gestational diabetes. J Clin Endocrinol Metab 2012;97:1720-1728.
48.
Ong K, Kratzsch J, Kiess W, Dunger D; ALSPAC Study Team: Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 2002;87:1041-1044.
49.
Ong K, Kratzsch J, Kiess W, Costello M, Scott C, Dunger D: Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab 2000;85:4266-4269.
50.
Adkins RM, Somes G, Morrison JC, Hill JB, Watson EM, Magann EF, Krushkal J: Association of birth weight with polymorphisms in the IGF2, H19, and IGF2R genes. Pediatr Res 2010;68:429-434.
51.
O'Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H, Humphries SE, Day IN: Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 1997;21:822-825.
52.
Gomes MV, Soares MR, Pasqualim-Neto A, Marcondes CR, Lobo RB, Ramos ES: Association between birth weight, body mass index and IGF2/ApaI polymorphism. Growth Horm IGF Res 2005;15:360-362.
53.
Sayer AA, Syddall H, O'Dell SD, Chen XH, Briggs PJ, Briggs R, Day IN, Cooper C: Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing 2002;31:468-470.
54.
Roth SM, Schrager MA, Metter EJ, Riechman SE, Fleg JL, Hurley BF, Ferrell RE: IGF2 genotype and obesity in men and women across the adult age span. Int J Obes Relat Metab Disord 2002;26:585-587.
55.
Soubry A, Schildkraut JM, Murtha A, Wang F, Huang Z, Bernal A, Kurtzberg J, Jirtle RL, Murphy SK, Hoyo C: Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort. BMC Med 2013;11:29.
56.
Perkins E, Murphy SK, Murtha AP, Schildkraut J, Jirtle RL, Demark-Wahnefried W, Forman MR, Kurtzberg J, Overcash F, Huang Z, Hoyo C: Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children. J Pediatr 2012;161:31-39.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.